@article{c7f990f7ada04208b465e7977eadbceb,
title = "Exposure-efficacy progression-free survival (PFS) analyses of breast cancer patients with germline BRCA1/2 mutations receiving talazoparib in the phase III EMBRACA trial",
author = "Y. Yu and M. Elmeliegy and Litton, \{J. K.\} and Tudor, \{I. C.\} and A. Czibere and J. Zheng and Wang, \{D. D.\}",
year = "2018",
month = oct,
day = "1",
doi = "10.1093/annonc/mdy272.295",
language = "English (US)",
volume = "29",
pages = "viii97",
journal = "Annals of oncology : official journal of the European Society for Medical Oncology",
issn = "0923-7534",
publisher = "Elsevier Ltd",
}